Moma Therapeutics
Clinical trials sponsored by Moma Therapeutics, explained in plain language.
-
New drug combo targets tough cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new oral drug called MOMA-313, alone or with another drug (olaparib), in people with advanced solid tumors that have certain DNA repair flaws. The main goals are to check safety and find the right dose. About 220 adults with cancers like prostate, p…
Phase: PHASE1 • Sponsor: MOMA Therapeutics • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New pill shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new oral drug, MOMA-341, alone or with other treatments, in people with advanced solid tumors that have specific genetic changes (MSI-H or dMMR). The main goal is to check safety and find the best dose. About 132 adults whose cancer has not responde…
Phase: PHASE1 • Sponsor: MOMA Therapeutics • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC